Sullivan, Bruyette, Speros & Blaney’s Natus Medical Inc NTUS Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,000	Closed	-$214K	–	212
2018 Q3	$214K	Hold	6,000	–	–	0.02%	157
2018 Q2	$207K	Hold	6,000	–	–	0.02%	159
2018 Q1	$202K	Hold	6,000	–	–	0.02%	158
2017 Q4	$229K	Hold	6,000	–	–	0.02%	155
2017 Q3	$225K	Hold	6,000	–	–	0.02%	146
2017 Q2	$224K	Hold	6,000	–	–	0.02%	136
2017 Q1	$236K	Hold	6,000	–	–	0.02%	130
2016 Q4	$209K	Hold	6,000	–	–	0.02%	133
2016 Q3	$236K	Hold	6,000	–	–	0.02%	128
2016 Q2	$227K	Buy	+6,000	New	+$201K	0.02%	119

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's NTUS Position: Q4 2018 in Review

Sullivan, Bruyette, Speros & Blaney sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 6,000 shares — an estimated $214K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in NTUS in Q2 2016 and held it in 10 quarters. The position peaked at $236K in Q1 2017. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

Sullivan, Bruyette, Speros & Blaney reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
Sullivan, Bruyette, Speros & Blaney sold 6,000 Natus Medical Inc shares in Q4 2018, an estimated $214K.
Sullivan, Bruyette, Speros & Blaney first reported a position in Natus Medical Inc in Q2 2016 and held it in 10 quarters.
Sullivan, Bruyette, Speros & Blaney's Natus Medical Inc position peaked at $236K in Q1 2017.
174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q4 2018, filed 7 Feb 2019.